Clinical Research on Tanreqing Injection Treatment of The Acute Lung Injury

Abstract

<strong>Objective:</strong> To discuss the clinical effect of Tanreqing injection in treatment of acute lung injury. <strong>Methods:</strong> 47 patients with acute lung injury in our hospital from January 2009 to February 2014 are selected and randomly divided into two groups. The control group has 24 cases and receives the conventional emergency treatment measures, including establishment of intravenous channel, loop support, oxygen inhalation, antibiotics application and primary trauma treatment, etc. There are 23 cases in experimental group, on the basis of treatment of the control group, they are treated with Tanreqing injection. The two groups are compared after treatment to study the clinical efficiency, blood gas index, SIRS score and the incidence of ARDS. <strong>Results: </strong>The treatment efficiency of patients with acute lung injury in experimental group is significantly higher than the control group (<em>p </em>< 0.05). After treatment, the blood gas index such as PO<sub>2</sub>, PCO<sub>2</sub>, PO<sub>2</sub>/FiO<sub>2</sub> and others and SIRS score of patient with acute lung injury in both groups are obviously improved, and the experimental group is significantly better than the control group (<em>p</em> < 0.05). At the same time, the incidence of ARDS of patients with acute lung injury in the experimental group is significantly lower than the control group (<em>p</em> < 0.05).<strong> Conclusion: </strong>The use of Tanreqing injection during the treatment of acute lung injury can effectively improve patients’ ventilation and alleviate symptoms of respiratory distress and has good prognosis.